lisdexamfetamine Vyvanse
Selected indexed studies
- Lisdexamfetamine. (Paediatr Drugs, 2007) [PMID:17407369]
- LISDEXAMFETAMINE (VYVANSE) USE ASSOCIATED WITH BRANCH RETINAL ARTERY OCCLUSION. (Retin Cases Brief Rep, 2024) [PMID:36007252]
- A systematic review of the safety of lisdexamfetamine dimesylate. (CNS Drugs, 2014) [PMID:24788672]
_Worker-drafted node — pending editorial review._
Connections
lisdexamfetamine Vyvanse is a side effect of
Sources
- Lisdexamfetamine. (2007) pubmed
- LISDEXAMFETAMINE (VYVANSE) USE ASSOCIATED WITH BRANCH RETINAL ARTERY OCCLUSION. (2024) pubmed
- A systematic review of the safety of lisdexamfetamine dimesylate. (2014) pubmed
- Lisdexamfetamine's Efficacy in Treating Attention Deficit Hyperactivity Disorder (ADHD): A Meta-Analysis and Review. (2024) pubmed
- Psychopharmacologic Management of Eating Disorders. (2022) pubmed
- Lisdexamfetamine. (2006) pubmed
- Amphetamine, past and present--a pharmacological and clinical perspective. (2013) pubmed
- Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review. (2022) pubmed
- Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial. (2025) pubmed
- Lisdexamfetamine-Associated Tonsure Trichotillomania. (2022) pubmed